| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPENDO.90287.2008 |
| P698 | PubMed publication ID | 18593850 |
| P50 | author | Florian Muller | Q43107131 |
| Ralph A. DeFronzo | Q58689309 | ||
| Holly Van Remmen | Q78838825 | ||
| P2093 | author name string | Yuhong Liu | |
| Muhammad A Abdul-Ghani | |||
| Devjit Tripathy | |||
| Rucha Jani | |||
| Franco Folli | |||
| Pengou Zuo | |||
| Alberto O Chavez | |||
| Marjorie Molina-Carrion | |||
| Zhi Chang | |||
| Bogdan Balas | |||
| Adriana Monroy | |||
| P2860 | cites work | Inhibitory effect of palmitate on the mitochondrial NADH:ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition | Q39373439 |
| Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. | Q39648063 | ||
| The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus | Q41176971 | ||
| Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes | Q42467298 | ||
| Palmitic acid opens a novel cyclosporin A-insensitive pore in the inner mitochondrial membrane | Q43613403 | ||
| Free fatty acid effects on mitochondrial permeability: an overview | Q43613406 | ||
| Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha | Q44043178 | ||
| Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. | Q44055110 | ||
| Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects | Q44155508 | ||
| Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance | Q44760628 | ||
| Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes | Q45199109 | ||
| Dose-response effect of elevated plasma free fatty acid on insulin signaling | Q46513253 | ||
| Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients | Q46774705 | ||
| Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle | Q46778032 | ||
| Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. | Q51554321 | ||
| Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. | Q51565080 | ||
| Skeletal muscle triglyceride levels are inversely related to insulin action. | Q51575343 | ||
| Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. | Q55033199 | ||
| Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle | Q58451168 | ||
| Biochemical and Osmotic Properties of Skeletal Muscle Mitochondria | Q59097012 | ||
| Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling | Q24530119 | ||
| Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | Q24629603 | ||
| The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | Q28190307 | ||
| Complex III releases superoxide to both sides of the inner mitochondrial membrane | Q28509539 | ||
| Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes | Q29614548 | ||
| Mitochondrial dysfunction and type 2 diabetes | Q29617913 | ||
| Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 | ||
| Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. | Q34126257 | ||
| Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy | Q34129374 | ||
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance | Q34577169 | ||
| Mitochondrial energy dissipation by fatty acids. Mechanisms and implications for cell death | Q35025248 | ||
| Burning fat: the structural basis of fatty acid beta-oxidation | Q35035239 | ||
| Metabolic and molecular basis of insulin resistance | Q35148800 | ||
| Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo | Q35578499 | ||
| Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus | Q35824553 | ||
| Pathogenesis of type 2 diabetes mellitus | Q35861736 | ||
| Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes | Q36356864 | ||
| Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 | ||
| P433 | issue | 3 | |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | E678-85 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance | |
| P478 | volume | 295 |
| Q43074217 | Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q64231858 | BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE Mice |
| Q93162842 | Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease |
| Q50961194 | Challenges to nutrition therapy in the pediatric critically ill obese patient. |
| Q43263022 | Chronic high fat feeding attenuates load-induced hypertrophy in mice. |
| Q33959764 | Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals |
| Q42718201 | Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes |
| Q39077948 | Di(2-ethylhexyl)phthalate exposure impairs insulin receptor and glucose transporter 4 gene expression in L6 myotubes |
| Q38480508 | Dietary Monounsaturated Fatty Acids but not Saturated Fatty Acids Preserve the Insulin Signaling Pathway via IRS‐1/PI3K in Rat Skeletal Muscle |
| Q33586726 | Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals |
| Q33648511 | Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation |
| Q34305184 | Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring |
| Q42515389 | FENOFIBRATE REVERSES CHANGES INDUCED BY HIGH-FAT DIET ON METABOLISM IN MICE MUSCLE AND VISCERAL ADIPOCYTES. |
| Q36216023 | Genetic ablation of calcium-independent phospholipase A(2)γ (iPLA(2)γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release |
| Q37577126 | In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion |
| Q48376266 | Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects |
| Q41861087 | Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction |
| Q33880303 | Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 |
| Q38153423 | Intracellular and extracellular adenosine triphosphate in regulation of insulin secretion from pancreatic β cells (β). |
| Q50627211 | Intramuscular triglyceride content precedes impaired glucose metabolism without evidence for mitochondrial dysfunction during early development of a diabetic phenotype. |
| Q34974500 | Is there a metabolic program in the skeletal muscle of obese individuals? |
| Q27315724 | Loss of UCP2 attenuates mitochondrial dysfunction without altering ROS production and uncoupling activity |
| Q84554424 | Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome |
| Q35854385 | Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function |
| Q35755204 | Metabolic support of the obese intensive care unit patient: a current perspective |
| Q96953430 | Mitochondrial Utilization of Competing Fuels Is Altered in Insulin Resistant Skeletal Muscle of Non-obese Rats (Goto-Kakizaki) |
| Q35045900 | Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy |
| Q28383016 | Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes |
| Q35665651 | Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle |
| Q37889277 | Mitochondrial pathophysiology and type 2 diabetes mellitus |
| Q36953482 | Mitochondrial plasticity in obesity and diabetes mellitus |
| Q46138359 | Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants |
| Q38207747 | Mitochondrial target of thiazolidinediones |
| Q90616775 | Multifaceted Actions of Succinate as a Signaling Transmitter Vary with Its Cellular Locations |
| Q36100203 | Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss |
| Q43210750 | Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells |
| Q38208411 | Nutritional care of the obese adult burn patient: a U.K. Survey and literature review |
| Q42317096 | Oleate induces KATP channel-dependent hyperpolarization in mouse hypothalamic glucose-excited neurons without altering cellular energy charge |
| Q33734125 | PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease |
| Q48220863 | Palmitate induces mitochondrial superoxide generation and activates AMPK in podocytes. |
| Q50988205 | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. |
| Q34082792 | Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance |
| Q53704324 | Reduced Skeletal Muscle Phosphocreatine Concentration in Type 2 Diabetic Patients: A Quantitative Image-Based Phosphorus-31 MR Spectroscopy Study. |
| Q34207748 | Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome |
| Q53701388 | Role of carnitine and its derivatives in the development and management of type 2 diabetes. |
| Q37624257 | Skeletal muscle insulin resistance is the primary defect in type 2 diabetes |
| Q37463518 | Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. |
| Q38326204 | Skeletal muscle respiratory capacity is enhanced in rats consuming an obesogenic Western diet. |
| Q26829731 | The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise |
| Q49906238 | The role of DNA-PK in aging and energy metabolism |
| Q33779662 | The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance |
| Q53784139 | Timosaponin B-II Ameliorates Palmitate-Induced Insulin Resistance and Inflammation via IRS-1/PI3K/Akt and IKK/NF-[Formula: see text]B Pathways. |
| Q34318248 | Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches |
| Q34357863 | Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury |
| Q42482372 | Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin. |
| Q46355683 | What Is Lipotoxicity? |
Search more.